Call it hype, a pipe dream, BS, misfolded, whatever.
I believe AMBS management is winding this spring so tight on so many things in the pipeline, that when AMBS puts on a full court press with DATA THAT WILL CHANGE LIVES AND MEDICINE FOREVER. this will take off. I can see ways to uplist with no reverse split.